Return to homepagePandemic Pact

COVID-19 Vaccines - Novel Approaches to Tackle a Novel Disease [Funder: MI4]

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Funder

    Other Funders (Canada)

  • Principal Investigator

    Momar Ndao, Michael Reed

  • Research Location

    Canada

  • Lead Research Institution

    McGill University

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    Innovation

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Thinking outside the box-and quickly-is critical if we are to generate solutions for the current COVID-19 crisis. To protect the population in the short and long-terms, infectious diseases experts Dr. Momar Ndao, Dr. Michael Reed and Dr. Martin Olivier are working to develop a COVID-19 vaccine by adapting and testing two established approaches based on the tuberculosis vaccine and adenovirus. Because both of the existing systems are approved for use in humans, developing a COVID-19 vaccine using the same principles could lead to a more rapid solution.